mercaptamine (cysteamine) bitartrate
Current shortage
The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
The TGA has assessed this shortage as critical impact. That is a judgement about how hard the medicine is to substitute in clinical care, not a prediction about any one person. If you take this medicine, speak to your pharmacist or doctor about what is available. Do not stop or change how you take it on your own.
1 product record on the Australian Register of Therapeutic Goods, listed in full below. The TGA last updated this information on 12 June 2026. Not medical advice.
The TGA does not publish a reason for a shortage, so Voxsanity cannot show one. Nothing on this page is an explanation of why supply is affected — that information is not in the source and is not inferred here.
This is national information. The TGA records shortages for Australia as a whole. There is no state, territory or pharmacy-level stock information in this data, and Voxsanity cannot tell you whether a particular pharmacy has a medicine in stock. Your pharmacist can.
Products affected
CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle
Capsule, hard · ARTG 60452
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Limited Availability The supplier reports limited stock.
- TGA impact rating
- Critical impact The TGA has assessed this shortage as critical impact. That is a judgement about how hard the medicine is to substitute in clinical care, not a prediction about any one person. If you take this medicine, speak to your pharmacist or doctor about what is available. Do not stop or change how you take it on your own.
- Reported from
- 8 July 2026 The TGA's dates span 3 months.
- Expected to be resolved
- 12 October 2026 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 12 June 2026
What the TGA says is being done
An overseas-registered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group Pty Ltd, can be contacted for details on supply on 1300 077 674.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
Where this comes from
Source: Medicine Shortage Reports Database, Therapeutic Goods Administration (TGA), © Commonwealth of Australia, reproduced with permission. The TGA does not endorse Voxsanity, and nothing here is presented as a TGA view. Shortage information is free for everyone on this site, with no account and no subscription.
To read the TGA's own entry for mercaptamine (cysteamine) bitartrate, open the TGA Medicine Shortage Reports Database and type mercaptamine (cysteamine) bitartrate into its filter box. The TGA's register has no direct link to an individual medicine, so this is the closest link that exists. General information about medicine shortages is on the TGA's medicine shortages page.
Voxsanity last read the register on 18 August 2026.
Not medical advice. Voxsanity republishes public government health data in plain English. Speak to your pharmacist or doctor about your own medicines. Do not stop or change how you take a medicine because of anything on this page.